Lenvima 8 MG daily dose 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8RY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,774
Award facts
- Contract value 100% obligated
- $10,773.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a 60-tablet quantity. This competitive, firm fixed-price delivery order was executed on January 2, 2026, with an ultimate completion date of January 26, 2026. The contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lenvima (lenvatinib) is a targeted cancer therapy used in the treatment of various malignancies, indicating this procurement supports military and federal healthcare system pharmaceutical needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The parent IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, with the Defense Logistics Agency planning to establish successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26FY8RY?
SPE2DR26FY8RY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FY8RY worth?
The government has obligated $10,774 on SPE2DR26FY8RY.
Is contract SPE2DR26FY8RY an order under another contract?
Yes. SPE2DR26FY8RY is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8RY competed?
The extent of competition for SPE2DR26FY8RY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award